GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trevena Inc (OTCPK:TRVN) » Definitions » Operating Margin %

TRVN (Trevena) Operating Margin % : -1,970.67% (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Trevena Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Trevena's Operating Income for the three months ended in Sep. 2024 was $-5.58 Mil. Trevena's Revenue for the three months ended in Sep. 2024 was $0.28 Mil. Therefore, Trevena's Operating Margin % for the quarter that ended in Sep. 2024 was -1,970.67%.

The historical rank and industry rank for Trevena's Operating Margin % or its related term are showing as below:

TRVN' s Operating Margin % Range Over the Past 10 Years
Min: -85393.55   Med: -1044.98   Max: 13486.84
Current: -5880.04


TRVN's Operating Margin % is ranked worse than
88.43% of 1011 companies
in the Biotechnology industry
Industry Median: -162.31 vs TRVN: -5880.04

Trevena's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Trevena's Operating Income for the three months ended in Sep. 2024 was $-5.58 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 was $-32.11 Mil.


Trevena Operating Margin % Historical Data

The historical data trend for Trevena's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trevena Operating Margin % Chart

Trevena Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -85,393.55 -960.74 -9,157.85 13,486.84 -1,129.22

Trevena Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,903.89 12,374.39 -49,390.00 -2,000.92 -1,970.67

Competitive Comparison of Trevena's Operating Margin %

For the Biotechnology subindustry, Trevena's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trevena's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Trevena's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Trevena's Operating Margin % falls into.



Trevena Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Trevena's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-35.288 / 3.125
=-1,129.22 %

Trevena's Operating Margin % for the quarter that ended in Sep. 2024 is calculated as

Operating Margin %=Operating Income (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=-5.577 / 0.283
=-1,970.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Trevena  (OTCPK:TRVN) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Trevena Operating Margin % Related Terms

Thank you for viewing the detailed overview of Trevena's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Trevena Business Description

Traded in Other Exchanges
N/A
Address
955 Chesterbrook Boulevard, Suite 110, Chesterbrook, PA, USA, 19087
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
Executives
Mark Corrigan director
Mark Demitrack officer: SVP, Chief Medical Officer 955 CHESTERBROOK BOULEVARD, SUITE 200, CHESTERBROOK PA 19087
Robert T Yoder officer: SVP, Chief Business Officer 955 CHESTERBROOK BOULEVARD, SUITE 110, SUITE 200, CHESTERBROOK PA 19087
Carrie L. Bourdow director, officer: President & CEO C/O TREVENA, INC., 1018 WEST 8TH AVENUE, SUITE A, KING OF PRUSSIA PA 19406
Patricia M. Drake officer: SVP, Chief Commercial Officer 245 FIRST STREET, SUITE 1800, CAMBRIDGE MA 02142
Barry Shin officer: SVP, CFO C/O TREVENA, INC., 955 CHESTERBROOK BLVD, SUITE 110, CHESTERBROOK PA 19087
Marvin Johnson director C/O TREVENA, INC., 955 CHESTERBROOK BOULEVARD, STE. 110, CHESTERBROOK PA 19087
Barbara Yanni director 1018 W. 8TH AVENUE, SUITE A, KING OF PRUSSIA PA 19406
Moulder Leon O Jr director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jason Raleigh Nunn director 1119 ST. PAUL STREET, BALTIMORE MD 21202
Scott Braunstein director C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR MI 48108
Michael R Dougherty director C/O ADOLOR CORP, 700 PENNSYLVANIA DR, EXTON PA 19341
Anne M. Phillips director C/O TREVENA, INC., 1018 WEST 8TH AVENUE, KING OF PRUSSIA PA 19406
Scott Applebaum officer: CLCO; SVP, Regulatory Affairs C/O TREVENA INC., 955 CHESTERBROOK BOULEVARD, SUITE 110, CHESTERBROOK PA 19087
John P. Hamill officer: Int. Prin. Fin. Off. and PAO 4092 NEW HOPE ROAD, FURLONG PA 18925

Trevena Headlines

From GuruFocus

Q3 2019 Trevena Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q1 2023 Trevena Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q2 2019 Trevena Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q4 2020 Trevena Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q1 2019 Trevena Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Trevena Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-09-2024

Q2 2022 Trevena Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q1 2020 Trevena Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024